KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Q3 2025 value amounting to $17.0 million.

  • Biomarin Pharmaceutical's Other Working Capital Changes fell 2097.52% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year increase of 4666.05%. This contributed to the annual value of $3.8 million for FY2024, which is 9249.43% down from last year.
  • Latest data reveals that Biomarin Pharmaceutical reported Other Working Capital Changes of $17.0 million as of Q3 2025, which was down 2097.52% from $8.8 million recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Other Working Capital Changes ranged from a high of $36.0 million in Q1 2023 and a low of -$42.8 million during Q1 2021
  • In the last 5 years, Biomarin Pharmaceutical's Other Working Capital Changes had a median value of $6.3 million in 2025 and averaged $2.6 million.
  • As far as peak fluctuations go, Biomarin Pharmaceutical's Other Working Capital Changes plummeted by 49978.03% in 2022, and later skyrocketed by 34939.46% in 2023.
  • Quarter analysis of 5 years shows Biomarin Pharmaceutical's Other Working Capital Changes stood at -$2.7 million in 2021, then tumbled by 499.78% to -$16.4 million in 2022, then surged by 44.73% to -$9.1 million in 2023, then plummeted by 78.5% to -$16.2 million in 2024, then skyrocketed by 205.4% to $17.0 million in 2025.
  • Its Other Working Capital Changes was $17.0 million in Q3 2025, compared to $8.8 million in Q2 2025 and $6.3 million in Q1 2025.